Cargando…

Combination of preoperative CEA and CA19-9 improves prediction outcomes in patients with resectable pancreatic adenocarcinoma: results from a large follow-up cohort

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies with a 5-year survival rate of <7%. Carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA) are often used to predict the outcome of the malignancy independently. However, the joint prognostic effect of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Guofeng, Liu, Xiaoyu, Wang, Xiaoyi, Jin, Dayong, Chen, Yi, Li, Guoping, Li, Changyu, Fu, Deliang, Xu, Wanghong, Wang, Xiaolin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338972/ https://www.ncbi.nlm.nih.gov/pubmed/28280354 http://dx.doi.org/10.2147/OTT.S116136

Ejemplares similares

Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of Cholangiocarcinoma
por: Fang, Tianyi, et al.
Publicado: (2019)

Effect of Perioperative CEA and CA24-2 on Prognosis of Early Resectable Pancreatic Ductal Adenocarcinoma
por: Li, Xiaojie, et al.
Publicado: (2020)

Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
por: He, Chaobin, et al.
Publicado: (2018)

Serum CA 19-9 and CEA Levels as a Prognostic Factor in Pancreatic Adenocarcinoma
por: Lee, Kyong Joo, et al.
Publicado: (2013)

Prognostic value of serum CEA and CA19-9 levels in pancreatic ductal adenocarcinoma
por: Ermiah, Eramah, et al.
Publicado: (2022)

The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer.
por: Lundin, J., et al.
Publicado: (1994)

The Clinical Role of Preoperative Serum CA19-9 and Carcinoembryonic Antigen (CEA) Levels in Evaluating the Resectability of Advanced Gallbladder Cancer
por: Ma, Wencong, et al.
Publicado: (2020)

Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma
por: Wang, Wei, et al.
Publicado: (2016)

Gemcitabine-Based Regional Intra-Arterial Infusion Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma
por: Liu, Xiaoyu, et al.
Publicado: (2016)

The Clinical Significance of CEA, CA19–9, and CA125 in Management of Appendiceal Adenocarcinoma
por: Yousef, Abdelrahman, et al.
Publicado: (2023)

Combined preoperative concentrations of CEA, CA 19-9, and 72-4 for predicting outcomes in patients with gastric cancer after curative resection
por: Liu, Xuechao, et al.
Publicado: (2016)

Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA: a multicenter retrospective cohort study
por: Li, Zhenhui, et al.
Publicado: (2022)

CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2017)

Clinical importance of serum CEA and CA-19-9 levels in oesophagogastric junction adenocarcinomas
por: Sert, Ozlem Zeliha, et al.
Publicado: (2020)

Preoperative CA19-9 levels predict disease-free survival and overall survival in pancreatic adenocarcinoma patients after resection
por: Guan, Shasha, et al.
Publicado: (2019)

Preoperative serum levels of CEA and CA 242 in colorectal cancer.
por: Carpelan-Holmström, M., et al.
Publicado: (1995)

Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.
por: Haglund, C.
Publicado: (1986)

Combined Evaluation of Preoperative Serum CEA and CA125 as an Independent Prognostic Biomarker in Patients with Early-Stage Cervical Adenocarcinoma
por: Huang, Genping, et al.
Publicado: (2020)

Association of Preoperative Serum Levels of CEA and CA15-3 with Molecular Subtypes of Breast Cancer
por: Zhao, Wenjing, et al.
Publicado: (2021)

Preoperative Serum CA125 Levels Predict the Prognosis in Hyperbilirubinemia Patients With Resectable Pancreatic Ductal Adenocarcinoma
por: Chen, Tao, et al.
Publicado: (2015)

CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA.
por: Haglund, C., et al.
Publicado: (1994)

Preoperative CRP(−)/CEA(−)/CA19-9(−)/non-T4 in Stage III Colorectal Cancer Is Favorable Risk for Recurrence
por: Ushigome, Mitsunori, et al.
Publicado: (2022)

Prognostic Values Of Preoperative Serum CEA And CA125 Levels And Nomograms For Young Breast Cancer Patients
por: Li, Xuan, et al.
Publicado: (2019)

Postoperative carcinoembryonic antigen (CEA) levels predict outcomes after resection of colorectal cancer in patients with normal preoperative CEA levels
por: Zhang, Chiming, et al.
Publicado: (2020)

A novel classifier based on three preoperative tumor markers predicting the cancer-specific survival of gastric cancer (CEA, CA19-9 and CA72-4)
por: Guo, Jing, et al.
Publicado: (2017)

Predictive Value of Preoperative Serum AFP, CEA, and CA19-9 Levels in Patients with Single Small Hepatocellular Carcinoma: Retrospective Study
por: Gan, Leijuan, et al.
Publicado: (2022)

The prognostic value of preoperative serum CA724 for CEA-normal colorectal cancer patients
por: Kuang, Jiaan, et al.
Publicado: (2020)

Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer
por: Luo, Hai, et al.
Publicado: (2020)

The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer.
por: Hall, N. R., et al.
Publicado: (1994)

Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
por: Lakemeyer, Leilani, et al.
Publicado: (2021)

The prognostic value of the postoperative serum CEA levels/preoperative serum CEA levels ratio in colorectal cancer patients with high preoperative serum CEA levels
por: Xie, Hai-Lun, et al.
Publicado: (2019)

Combined Detection of Preoperative Neutrophil-to-Lymphocyte Ratio and CEA as an Independent Prognostic Factor in Nonmetastatic Patients Undergoing Colorectal Cancer Resection Is Superior to NLR or CEA Alone
por: Zhan, Xiaoli, et al.
Publicado: (2017)

Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors
por: Lertkhachonsuk, Arb‐aroon, et al.
Publicado: (2020)

Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer
por: Liang, Yao, et al.
Publicado: (2016)

Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors
por: Śmigielski, Jacek A., et al.
Publicado: (2013)

Clinical value of preoperative serum CA 19-9 and CA 125 levels in predicting the resectability of hilar cholangiocarcinoma
por: Hu, Hai-Jie, et al.
Publicado: (2016)

Detection of CTCs in portal vein was associated with intrahepatic metastases and prognosis in patients with advanced pancreatic cancer
por: Liu, Xiaoyu, et al.
Publicado: (2018)

The effect of glycemic control on CEA, CA 19-9, amylase and lipase levels
por: Ata, Naim, et al.
Publicado: (2014)

Raised CA19–9 and CEA have prognostic relevance in gallbladder carcinoma
por: Sachan, Ashish, et al.
Publicado: (2020)

Palliative Gastrectomy Prolongs Survival of Metastatic Gastric Cancer Patients with Normal Preoperative CEA or CA19-9 Values: A Retrospective Cohort Study
por: Chiu, Chang-Fang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n442sc2qpk445l9sdha40a72lv